The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis

Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections

(2016) A. Gomez-Simmonds et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests

(2016) Shio-Shin Jean et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Efficacy of Tigecycline for Secondary Acinetobacter Bacteremia and Factors Associated with Treatment Failure

(2015) Bo-Huang Liou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins

(2015) M.S. de Oliveira et al.   CLINICAL MICROBIOLOGY AND INFECTION

Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia

(2015) Aristine Cheng et al.   CRITICAL CARE MEDICINE

Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems

(2014) George L. Daikos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Results of a Multicenter, Controlled, Randomized Clinical Trial Evaluating the Combination of Piperacillin/Tazobactam and Tigecycline in High-Risk Hematologic Patients With Cancer With Febrile Neutropenia

(2014) Giampaolo Bucaneve et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit

(2014) Matthaios Papadimitriou-Olivgeris et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Tigecycline: an update

(2013) Gary E. Stein et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis

(2013) Laszlo Lauf et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials

(2013) Paul C. McGovern et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens

(2012) Zubair A. Qureshi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

(2012) M. Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness and Safety of Tigecycline: Focus on Use for Approved Indications

(2012) K. Z. Vardakas et al.   CLINICAL INFECTIOUS DISEASES

Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials

(2012) P. Prasad et al.   CLINICAL INFECTIOUS DISEASES

Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: Susceptibility and clinical outcome

(2012) Nak-Hyun Kim et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment

(2011) O. Zarkotou et al.   CLINICAL MICROBIOLOGY AND INFECTION

Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy

(2011) R. Guner et al.   INFECTION

Efficacy and safety of tigecycline: a systematic review and meta-analysis

(2011) Dafna Yahav et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis

(2011) Efthimia Tasina et al.   LANCET INFECTIOUS DISEASES

Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials

(2009) David Gardiner et al.   CLINICAL INFECTIOUS DISEASES

Management of complicated infections in the era of antimicrobial resistance: the role of tigecycline

(2009) David P Nicolau   EXPERT OPINION ON PHARMACOTHERAPY

P284 Prospective multicenter trial of tigecycline for treatment of central venous catheter (CVC)-related coagulase-negative staphylococcal (CoNS) bacteremia

(2009) D. Maki et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Tigecycline-induced acute pancreatitis: case report and literature review

(2009) Whitney Y. Hung et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

(2009) N. C. Gordon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

(2008) Cristina Tanaseanu et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study

(2008) I. Florescu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY